PARP inhibition in UV-associated angiosarcoma preclinical models

PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....

Descripción completa

Detalles Bibliográficos
Autores principales: Weidema, Marije E., Desar, Ingrid M. E., Hillebrandt-Roeffen, Melissa H. S., van Erp, Anke E. M., Masuzawa, Mikio, Flucke, Uta E., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310857/
https://www.ncbi.nlm.nih.gov/pubmed/34085099
http://dx.doi.org/10.1007/s00432-021-03678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310857/
https://www.ncbi.nlm.nih.gov/pubmed/34085099
http://dx.doi.org/10.1007/s00432-021-03678-4

Ejemplares similares